Skip to main content
Premium Trial:

Request an Annual Quote

Startup Coral Genomics Wins $2M SBIR Grant From NIH

NEW YORK – Coral Genomics, a startup aiming to expand the clinical utility of genomics for diverse populations through diagnostics, said on Tuesday that it has won a $2 million Small Business Innovation Research grant from the National Institutes of Health.

The Phase II award, from the National Human Genome Research Institute, will fund a study to apply the firm's low-depth next-generation sequencing method to aid therapy selection for patients with inflammatory bowel disease. The firm will use low-coverage whole-genome and whole-exome sequencing driven by its new sample pooling approach, which it says can reduce sequencing costs by 50 percent.

Coral will process patient samples at its lab, which recently received CLIA certification, the firm said in a statement, adding that initial results from the two-year study will be available at the end of this year.

The new funding follows a Phase I SBIR award last year that focused on library preparation strategies. Since then, Coral has added functional assays to improve drug selection predictions across age, gender, and race.

Based in San Francisco and founded in 2018, Coral is generating new data sets to supplement large-scale biobank data and using that information to develop diagnostics used in therapy selection. The firm integrates molecular, functional, and clinical factors.

According to the grant abstract, Coral has developed "a new sample pooling approach capable of sequencing hundreds of samples with less than one week of wait time" and a "real-time analysis platform capable of returning variant calls within two hours of sequencing completion."

Coral Genomics has received funding from Soma Capital, Baidu Ventures, and Hemisphere Ventures, according to those investors' websites.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.